1 / 5

Fusion Biopsy Market

Fusion Biopsy Market

aaronmuller
Download Presentation

Fusion Biopsy Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fusion Biopsy Market Size 2020, By Biopsy Route (Transrectal, Transperineal) End Use (Hospitals, Diagnostic Centers, Ambulatory Care Centers) Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) and Forecast 2021 to 2028 Single Use License: US$ 4400 Request Sample

  2. Fusion Biopsy Market Size and Share 2028 • The global fusion biopsy market is projected to reach USD 1,001.2 million by 2028, growing at a CAGR of 11.1%. Growing incidence of prostate cancer, high specificity of fusion biopsy, and increasing acceptance of multiparametric MRI in prostate cancer care are some of the factors driving the growth of the global fusion biopsy market. • Adroit Market Research report on global Fusion biopsy market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global Fusion biopsy market have been studied in detail. • Prostate cancer is the second most frequently diagnosed cancer worldwide, and the fifth leading cause of cancer death in men. Most guidelines recommend screening for prostate cancer for well-informed men with more than seven to ten years of life expectancy. The process involves performing a clinical history, digital rectal examination (DRE) and serum testing of prostate specific antigen (PSA). Prostate biopsy is performed on the basis of screening results, and remains the gold standard for diagnosis.

  3. Fusion Biopsy Market Size and Share 2028 • The global fusion biopsy market is categorized based on biopsy route and end-use. On the basis of biopsy route, the market is segmented into transrectal, and transperineal. The transrectal segment dominated the market in 2020. Transrectal ultrasound guided prostate biopsy (TRUS-biopsy) is most offered worldwide. Transperineal biopsy (TPP-biopsy), on the other hand, has been gaining popularity due to its superior sensitivity and lower rate of sepsis. • North America dominated the market for fusion biopsy in 2019, while Asia Pacific is set to grow at a highest CAGR due to advances in oncology procedures. Key players of the global fusion biopsy market include MedCom, KOELIS, ESAOTE SPA, Focal Helathcare, UC-Care Medical Systems Ltd., GeoScan Medical among others. • Key segments of the global fusion biopsy market • Biopsy Route Overview, 2018-2028 (USD Million) • Transrectal • Transperineal • End Use Overview, 2018-2028 (USD Million) • Hospitals • Diagnostic Centers • Ambulatory Care Centers

  4. Fusion Biopsy Market Size and Share 2028 •  Regional Overview, 2018-2028 (USD Million) • North America • U.S. • Canada • Europe • Germany • United Kingdom • France • Rest of Europe • Asia Pacific • China • Japan • India • Rest of Asia Pacific • Latin America • Middle East & Africa

  5. About Us Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps. Our analysts have tracked high growth markets in chemicals & materials, healthcare & pharmaceuticals, semiconductor & electronics, energy & power, food & retail, consumer goods, technology, and machinery & equipment sectors across the world to identify new opportunities, potential customers, prepare go-to-market (GTM) strategies, identify segments for revenue growth for companies, and many more. US Headquarters3131 McKinney Ave Ste 600 Dallas, TX 75204 ,U.S.A  Phone: +1 2106672421 Email: sales@adroitmarketresearch.com

More Related